Bumper Offer - Urjas oil Just @ Rs. 1
Nasivion Baby 0.01% Nasal Drop is a commercial drug that is prescribed in the form of Drops. It is typically used for the treatment of Blocked Nose. The alternative uses of Nasivion Baby 0.01% Nasal Drop have also been explained below.
The right dosage of Nasivion Baby 0.01% Nasal Drop depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Nasivion Baby 0.01% Nasal Drop as well, which are listed below. Usually, these side effects of Nasivion Baby 0.01% Nasal Drop go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Nasivion Baby 0.01% Nasal Drop has a Unknown effect for pregnant women and Unknown effect on lactating mothers. Further, the section on Nasivion Baby 0.01% Nasal Drop related warnings talks about Nasivion Baby 0.01% Nasal Drop's effects on the liver, heart and kidney.
Nasivion Baby 0.01% Nasal Drop is not recommended if you suffer from certain medical conditions as it can have adverse effects. Glaucoma are examples of such conditions. Other contraindications of Nasivion Baby 0.01% Nasal Drop have been discussed in the sections ahead.
Drug interactions for Nasivion Baby 0.01% Nasal Drop have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Nasivion Baby 0.01% Nasal Drop, it is important to know that it is safe while driving, and is habit-forming.
Nasivion Baby 0.01% Nasal Drop is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Nasivion Baby 0.01% Nasal Drop is used -
Moderate
Mild
Is the use of Nasivion Baby 0.01% Nasal Drop safe for pregnant women?
The effects of Nasivion on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Nasivion Baby 0.01% Nasal Drop safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Nasivion for breastfeeding women are not known.
What is the effect of Nasivion Baby 0.01% Nasal Drop on the Kidneys?
Nasivion may have mild side effects on the kidneys.
What is the effect of Nasivion Baby 0.01% Nasal Drop on the Liver?
Nasivion may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Nasivion Baby 0.01% Nasal Drop on the Heart?
You can take Nasivion without any fear of damage to the heart.
Nasivion Baby 0.01% Nasal Drop should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Nasivion Baby 0.01% Nasal Drop unless your doctor advises you to do so -
Is this Nasivion Baby 0.01% Nasal Drop habit forming or addictive?
Nasivion Baby 0.01% Nasal Drop is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Nasivion Baby 0.01% Nasal Drop does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, the use of Nasivion Baby 0.01% Nasal Drop is considered safe.
Is it able to treat mental disorders?
Nasivion Baby 0.01% Nasal Drop is unable to treat or cure mental disorders.
Interaction between Food and Nasivion Baby 0.01% Nasal Drop
Information is not available on the interaction of any foods with Nasivion Baby 0.01% Nasal Drop, due to a lack of research on this.
Interaction between Alcohol and Nasivion Baby 0.01% Nasal Drop
No research has been done on this till date. Therefore, it is not known what the effect of taking Nasivion Baby 0.01% Nasal Drop with alcohol will be.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Allegra® (fexofenadine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 163,166
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 566
